Definium Therapeutics
Price & Volume
Stats
See more52W Range | $6.34-$26.25 |
Market Cap | $2.6B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.50 |
News
See moreYahoo Finance • 12 days ago
Generalized Anxiety Disorder Market Forecast Shows Strong CAGR During the Forecast Period (2026-2036) Driven by Innovative Therapies | DelveInsight
Yahoo Finance • 29 days ago
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
Yahoo Finance • 2 months ago
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
Yahoo Finance • 2 months ago
Trump issues executive order on psychedelic drugs
About
CEO | Mr. Robert Barrow |
Address | One World Trade Center, New York, NY, United States, 10007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 105 |